Two directors resign from Apogee board; board shrinks from 9 to 7

Apogee Therapeutics, Inc.

Andrew Gottesdiener, M.D. and Peter Harwin notified Board of resignations effective May 11, 2026.
Resignations are not due to any disagreement with Company's operations, policies or practices.
Board size will be reduced from nine to seven directors effective May 11, 2026.
No replacements announced; CEO Michael Henderson remains in role.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.